Remove 2016 Remove Doctors Remove Synthetic Chemistry
article thumbnail

Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company Growth and Development

The Pharma Data

Kazumi holds a PhD in Synthetic Chemistry from UC Berkeley. Lisa began her career as Assistant Professor at Washington University School of Medicine, following a post-doctoral cardiovascular fellowship at the University of Chicago. She is also a Board member of the Sandford Burnham Prebys Institute.